Delivery Order SPE2DR25D1100-SPE2DR26FCK1D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of CABENUVA ER 600 MG-900 MG suspension in 6 mL quantities, valued at $38,169.00 under a firm fixed-price arrangement. This non-competitive set-aside delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL units, with a contract ceiling value of $4,022.43 and an ultimate completion date of November 13, 2025. This firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a $38,169 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for CABENUVA ER 600 MG-900 MG Suspension in 6 mL units. This firm fixed-price delivery order, which represents a child contract action under AmerisourceBergen's larger pharmaceutical supply agreements, is scheduled for completion by September 18, 2025, with performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with...
- The Defense Logistics Agency awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg–900 mg suspension (6 mL) with a completion date of September 30, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on April 21, 2025, with a ceiling value of $7,633.80 and an ultimate completion date of May 12, 2025. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL quantities. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $59,619.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 MG-600 MG suspension (4 mL), a long-acting injectable antiretroviral medication. The contract, issued on August 29, 2025, with ultimate completion by September 22, 2025, represents a non-competitive, non-set-aside award leveraging the vendor's existing DLA contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $5,078.08 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 mg-600 mg suspension in 4 mL formulation, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $7,633.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 ml units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CABENUVA is an injectable HIV treatment medication, reflecting the company's role in...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCK1DDelivery Order
The Defense Logistics Agency awarded a $4,022.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL) with an ultimate completion date of November 13, 2025. This competitively awarded, non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The CABENUVA product being procured under this delivery order addresses federal medical supply requirements for the Defense Health Agency and other government healthcare systems, demonstrating the contractor's role as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 10/22/25 |